The Medical Council of Thailand has filed a petition with the Supreme Administrative Court to review the National Health Security Office’s (NHSO) initiative allowing pharmacists in the “Warm Community Pharmacies” program to prescribe medications for 16 groups of minor illnesses. While the initiative aims to provide quick access to treatment and reduce hospital overcrowding, the Medical Council expressed concerns over patient safety.

In a recent statement, the Medical Council outlined the risks associated with this program. They emphasized that pharmacists diagnosing and prescribing medication without proper medical examinations could lead to serious consequences. For example, headaches or abdominal pain—deemed minor symptoms—might be indicators of severe conditions like a brain hemorrhage or a ruptured appendix, requiring urgent medical attention. The Council highlighted that pharmacists lack the training and tools necessary for thorough diagnosis, such as physical exams and laboratory testing.

The Council argued that this approach risks delayed or incorrect treatment, potentially resulting in life-threatening complications or increased drug resistance. They noted that while similar models exist in other countries, they involve clear guidelines and collaboration between doctors and pharmacists to safely manage patient care—standards not adequately addressed in this initiative.

Despite attempts to negotiate with the NHSO and the Pharmacy Council to amend the program for greater patient safety, no resolution has been reached. As a result, the Medical Council resorted to legal action to temporarily halt and reassess the program to ensure it aligns with medical standards and prioritizes patient safety.

The Council expressed its willingness to work collaboratively with relevant organizations to develop a more effective, safe, and accessible healthcare system. However, given the case is now under judicial review, further public comments will be made cautiously to avoid influencing court proceedings.